Search results
Showing 61 to 75 of 1483 results for patients and public
In development Reference number: GID-TA11554 Expected publication date: TBC
Glycopyrronium bromide cream for treating severe primary axillary hyperhidrosis [ID6487]
In development Reference number: GID-TA11628 Expected publication date: TBC
In development Reference number: GID-TA11819 Expected publication date: 03 September 2026
In development Reference number: GID-TA10143 Expected publication date: TBC
Pirtobrutinib for untreated chronic lymphocytic leukaemia or small lymphocytic lymphoma [ID6397]
In development Reference number: GID-TA11501 Expected publication date: 24 February 2027
In development Reference number: GID-TA11502 Expected publication date: 02 December 2026
Plozasiran for treating familial chylomicronaemia syndrome [ID6593]
In development Reference number: GID-TA11793 Expected publication date: 17 September 2026
Aficamten for treating symptomatic obstructive hypertrophic cardiomyopathy [ID6575]
In development Reference number: GID-TA11742 Expected publication date: 29 July 2026
Nivolumab with ipilimumab for untreated advanced hepatocellular carcinoma [ID6239]
In development Reference number: GID-TA11116 Expected publication date: 11 November 2026
This guideline covers how to increase uptake of the free flu vaccination among people who are eligible. It describes ways to increase awareness and how to use all opportunities in primary and secondary care to identify people who should be encouraged to have the vaccination.
In development Reference number: GID-TA10990 Expected publication date: TBC
In development Reference number: GID-TA11772 Expected publication date: 03 September 2026
In development Reference number: GID-TA10981 Expected publication date: TBC
Larotrectinib for treating NTRK fusion-positive advanced solid tumours (MA review of TA630) [ID6292]
In development Reference number: GID-TA11565 Expected publication date: TBC
In development Reference number: GID-TA11643 Expected publication date: TBC